Animuscure Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 2

Animuscure General Information

Description

Developer of a pharmaceutical drug designed to treat sarcopenia and muscle disease. The company develops drugs for sarcopenia treatment and muscle disease based on increased muscle differentiation to improve lifespan and quality of life by overcoming muscle aging, enabling elderly people to improve their muscle health.

Contact Information

Website
www.animuscure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number B102, 90
  • Cheongpa-ro 47-gil, Yongsan-gu
  • Seoul, 04310
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
LOHAS & Wellness, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Number B102, 90
  • Cheongpa-ro 47-gil, Yongsan-gu
  • Seoul, 04310
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Animuscure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 03-Jul-2022 Completed Clinical Trials - Phase 2
1. Seed Round 10-Jun-2020 Completed Startup
To view Animuscure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Animuscure Patents

  • 48

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 25

    Pending

  • Expiring in next 12 mo

Animuscure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026142059-A1 Composition comprising bindarit for preventing or treating heart disease Pending 27-Dec-2024
WO-2026117017-A1 Use of prmt7 protein or gene expressing same for preventing or treating heart disease Pending 28-Nov-2024
WO-2026116838-A1 Method for producing heart organoid from pluripotent stem cells through elongation and looping, heart organoid produced thereby, and use thereof Pending 27-Nov-2024
WO-2026038834-A1 Method for producing senescent neuromuscular organoid, senescent neuromuscular organoid produced thereby, and use thereof Pending 12-Aug-2024
JP-2026517880-A Culture medium composition for neuromuscular organoids and method for producing neuromuscular organoids Pending 09-May-2023 C12N5/0658
To view Animuscure’s complete patent history, request access »

Animuscure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Animuscure Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
C&Venture Partners Venture Capital Minority
KC Tech Corporation Minority
To view Animuscure’s complete investors history, request access »

Ready to get started?

Request a free trial

Animuscure FAQs

  • When was Animuscure founded?

    Animuscure was founded in 2020.

  • Where is Animuscure headquartered?

    Animuscure is headquartered in Seoul, South Korea.

  • What is the size of Animuscure?

    Animuscure has 12 total employees.

  • What industry is Animuscure in?

    Animuscure’s primary industry is Drug Discovery.

  • Is Animuscure a private or public company?

    Animuscure is a Private company.

  • What is Animuscure’s current revenue?

    The current revenue for Animuscure is .

  • Who are Animuscure’s investors?

    C&Venture Partners and KC Tech have invested in Animuscure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process